Future trends in incidence and long-term survival of metastatic cancer in the United States.
Nicholas L HudockKyle ManiChachrit KhunsriraksakulVonn WalterLarissa NekhlyudovMing WangEric J LehrerMaria R HudockDajiang J LiuDaniel E SprattNicholas G ZaorskyPublished in: Communications medicine (2023)
By 2040, the distribution of metastatic cancer patients is predicted to shift in predominance from invariably fatal to indolent cancers subtypes. Continued research on metastatic cancers is important to guide health policy and clinical intervention efforts, and direct allocations of healthcare resources.